Platelet-derived extracellular vesicles (EVs) is a term that encompasses a heterogeneous
population of small membrane-enclosed vesicles containing a rich molecular cargo …

What is the advantage of knowing that statins might prevent venous thromboembolism
(VTE), as suggested by Doggen et al.[1] and others [2, 3](see Table 1)? Even if it can be …

Elevated circulating platelet-derived extracellular vesicles (EVs) have been reported in
conditions associated with thrombotic risk. The present study aimed to assess the …

Extracellular vesicles (EVs) in human blood are a potential source of biomarkers. To which
extent anticoagulation affects their concentration, cellular origin and protein composition is …

Statin drugs have antithrombotic biochemical effects [1]. Two articles in this issue of the
Journal of Thrombosis and Haemostasis report that statin use may prevent venous …

Cells release diverse types of vesicles constitutively or in response to proliferation, injury,
inflammation, or stress. Extracellular vesicles (EVs) are crucial in intercellular …

Microvesicles (MVs) are small (0.1–1 µm) membrane vesicles released from activated cells.
The surface of MVs can be highly procoagulant due to the presence of the procoagulant …

Microparticles (MP) are small membrane vesicles that are released from cells upon
activation or during apoptosis. Cellular MP in body fluids constitute a heterogeneous …

Small cell lung cancer (SCLC) patients have augmented risk of developing venous
thromboembolism, but the mechanisms triggering this burden on the coagulation system …